Category: BRIEFING
First Oral Drug Reducing Risk of Blood Loss in Liver Disease Patients Gets Approved
2016 founded company, Dova Pharma's first drug, Doptelet received US FDA approval as the first oral treatment option to reduce the risk of blood loss in patients with chronic liver disease.
Melinta Therapeutics Receives CARB-X Funding to Develop New Antibiotics Against Multiple “Superbugs”
No new class of antibiotics has been approved over the last fifty years. Currently, there are 10 new classes of antibiotics in the CARB-X portfolio, if any one of them reaches to patients, it would be the first new class of antibiotic to be approved, since 1962. Melinta Therapeutics funding.
First CAR-T GeneTherapy for Pediatric Blood Cancer ‘Kymriah’ Now Treats Adult Patients
Novartis' Kymriah has extended the horizon of personalized cancer treatment. It is the only CAR-T therapy that has received FDA approval for two types of cancer indications- non-Hodgkin lymphoma and B-cell ALL.
First Drug to Treat Polycystic Kidney Disease Bags FDA Approval
First drug treatment- Jynarque (tolvaptan) to slow down the decline in kidney function in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) received USFDA approval. The drug is developed by Japanese biopharma, Otsuka Pharma.
This Cancer Biotech Startup Raises Over 40% Higher in IPO than Proposed Goal
The cancer startup develops novel immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer. The company is developing immuno-oncology drugs which could be combined with existing immunotherapies to enhance the efficiency of detecting and killing cancer cells.
AstraZeneca Commits $90 Million in 5 Years to Improve Healthcare in India
Over the next five years, pharma giant, AstraZeneca will invest $90 million in India to improve the overall health outcomes in the country, by promoting innovation, skill development, and quality manufacturing.
First-of-its-Kind FDA-Cleared Device Launched to Enhance Tear Production
Allergan has launched the first and the only FDA-cleared device TrueTear® to temporarily increase tear production in adult patients with inadequate tear production.
Delhi-Based Healthcare Fintech Startup Raises $1 M in Seed Funding Round
Delhi-based healthcare financing startup, LetsMD has raised $1 million a pre-series A funding round led by SRI Capital.
First AI-Based Diabetic Retinopathy Detection Device Gets FDA Approval
The artificial intelligence (AI) based device called IDx-DR received US FDA approval for the screening of diabetic retinopathy- a common eye disease in diabetic patients that could lead to vision impairment and blindness.
Potential New Medicine ‘Moxetumomab Pasudotox’ under FDA Priority Review for a Rare Leukemia
AstraZeneca’s leukemia drug, Moxetumomab pasudotox has received Priority Review designation from the US FDA for the treatment of adult patients ...